Holmbom M, Giske CG, Fredrikson M, et al. A 14-year survey in a Swedish county reveals a pronounced enhance in bloodstream infections (BSI). Comorbidity – an unbiased danger issue for each BSI and mortality. PLOS ONE. 2016;11:e0166527.
Kontula KSK, Skogberg Ok, Ollgren J, et al. Inhabitants-based examine of blood stream an infection incidence and mortality charges, Finland, 2004-2018. Emerg Infect Dis. 2021;27:2569.
Verway M, Brown KA, Marchand-Austin A, et al. Prevalence and mortality related to bloodstream organisms: a population-level retrospective cohort examine. J Clin Microbiol. 2022;60:e0242921.
Marquet Ok, Liesenborgs A, Bergs J, et al. Incidence and end result of inappropriate hospital empiric antibiotics for extreme an infection: a scientific evaluation and meta-analysis. Crucial care. 2015;19:63.
Seymour CW, Gesten F, Prescott HC, et al. Time to therapy and mortality throughout obligatory emergency look after sepsis. N English J Med. 2017;376:223544.
Kalil AC, Johnson DW, Lisco SJ, et al. Objective-oriented early remedy for sepsis: A brand new resolution for discordant survival outcomes in scientific trials. Crucial Care Med. 2017;45:60714.
Evans L, Rodi A, Alhazzani W, et al. Surviving sepsis marketing campaign: worldwide pointers for the administration of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181247.
Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile an infection: Replace of the systematic evaluation and meta-analysis. J Antimicrob Chemother. 2014;69:88191.
Bell BG, Schellevis F, Stobberingh E, et al. A scientific evaluation and meta-analysis of the consequences of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.
Hiensch R, Poeran J, Saunders-Hao P, et al. Affect of an e-sepsis initiative on antibiotic use and the emergence of healthcare amenities Clostridium difficile an infection charges. Am J Infect Management. 2017;45:1091100.
Cangemi R, Falcone M, Taliani G, et al. Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia. Ann Am Thorac Soc. 2019;16:918.
Falcone M, Bassetti M, Tiseo G, et al. Time to acceptable antibiotic remedy is a predictor of end result in sufferers with Klebsiella pneumoniae bloodstream an infection that produces KPC. Crit Care (London English). 2020;24:29.
Zasowski EJ, Claeys KC, Lagnf AM, et al. Time is of the essence: The impression of delayed antibiotic remedy on affected person outcomes in hospital-onset enterococcal bloodstream infections. Clin infects Dis. 2016;62:124250.
Lodise TP Jr, Patel N, Kwa A, et al. Predictors of 30-day mortality amongst sufferers with Pseudomonas aeruginosa bloodstream infections: Affect of delayed collection of acceptable antibiotics. Chemother antimicrobial brokers. 2007;51:35105.
Oliva A, Volpicelli L, Di Bari S, et al. Impact of ceftazidime/avibactam plus phosphomycin mixture on 30-day mortality in sufferers with bloodstream infections brought on by KPC-producing Klebsiella pneumoniae: outcomes of a multicenter retrospective examine. JAC Antimicrob Resist. 2022;4:dlac121.
Friedman ND, Kaye KS, Stout JE, et al. Healthcare-associated bloodstream infections in adults: A motive to alter the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:7917.
Singer M, Deutschman CS, Seymour CW, et al. The third worldwide consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:80110.
CDC/NHSN surveillance definitions for particular varieties of infections. https://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf.
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, broadly drug-resistant, and drug-resistant micro organism: a world professional proposal for interim normal definitions for acquired resistance. Clin Microbiol Infect. 2012;18:26881.
Kadri SS, Lai YL, Warner S, et al; forming the Nationwide Institutes of Well being Antimicrobial Resistance Outcomes Analysis Initiative (NIH-ARORI), et al. Inappropriate empirical antibiotic remedy for bloodstream infections based mostly on discordant in vitro susceptibilities: A retrospective cohort evaluation of prevalence, predictors, and danger of mortality in US hospitals. Contaminated Lancet Dis. 2021;21:24151.
Ohnuma T, Chihara S, Costin B, et al. Affiliation of acceptable empiric antimicrobial remedy with in-hospital mortality in sufferers with bloodstream infections in america. JAMA community open. 2023;6:e2249353.
Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections brought on by KPC-producing Klebsiella pneumoniae: Significance of mixture remedy. Clin infects Dis. 2012;55:94350.
Qureshi ZA, Paterson DL, Potoski BA, et al. Therapy end result of bacteraemia as a result of KPC-producing Klebsiella pneumoniae: superiority of mixed antimicrobial regimens. Chemother antimicrobial brokers. 2012;56:210813.
Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Lowering mortality by antibiotic mixture schemes and the function of carbapenems. Chemother antimicrobial brokers. 2014;58:232228.
Falcone M, Russo A, Iacovelli A et al. Predictors of end result in ICU sufferers with septic shock brought on by Klebsiella pneumoniae carbapenemase-producing Ok. pneumoniae. Clin Microbiol Infect 2016.
Hu Y, Li L, Li W, et al. Mixture antibiotic remedy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and potential research. Int J Antimicrobial brokers. 2013;42:4926.
Gomez-Simmonds A, Nelson B, Eiras DP, et al. Mixture regimens for the therapy of carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Chemother antimicrobial brokers. 2016;60:360107.
Paul M, Benuri-Silbiger I, Soares-Weiser Ok, et al. Beta-lactam monotherapy versus beta-lactam-aminoglycoside mixture remedy for sepsis in immunocompetent sufferers: systematic evaluation and meta-analysis of randomized trials. BMJ extension. 2004;328:668.
Safdar N, Handelsman J, Maki DG. Does mixture antimicrobial remedy scale back mortality in Gram-negative bacteremia? A meta-analysis. Contaminated Lancet Dis. 2004;4:51927.
Kumar A, Safdar N, Kethireddy S, et al. A survival advantage of mixture antibiotic remedy for extreme infections related to sepsis and septic shock relies upon solely on the chance of dying: a meta-analytic/meta-regression examine. Crucial care Med. 2010;38:165164.
Gutirrez-Gutirrez B, Salamanca E, de Cueto M et al. For REIPI/ESGBIS/INCREMENT researchers. Impact of acceptable mixture remedy on the mortality of sufferers with bloodstream infections as a result of carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort examine. Contaminated Hand Dis 2017; launched on-line April 22.
Rodi A, Evans LE, Alhazzani W, et al. Surviving Sepsis Marketing campaign: Worldwide pointers for the administration of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486552.
Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic evaluation and meta-analysis of the efficacy of acceptable empiric antibiotic remedy for sepsis. Chemother antimicrobial brokers. 2010;54:485163.
Puerta-Alcalde P, Cardozo C, Surez-Lled M, et al. Present time to constructive blood cultures in febrile neutropenia: a device to be used in administration de-escalation methods. Clin Microbiol Infect. 2018;25:44753.
Deurenberg RH, Bathoorn E, Chlebowicz MA, et al. Software of subsequent era sequencing in scientific microbiology and an infection prevention. J Biotechnology. 2017;243:1624.